Novanta Inc. (NOVT)
| Previous Close | 156.25 |
| Open | 157.11 |
| Bid | 158.31 x 100 |
| Ask | 160.59 x 100 |
| Day's Range | 156.37 - 159.78 |
| 52 Week Range | 111.20 - 187.61 |
| Volume | |
| Avg. Volume | 135,382 |
| Market Cap | 5.778B |
| Beta (5Y Monthly) | 1.33 |
| PE Ratio (TTM) | 78.90 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Novanta to Present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024
BEDFORD, Mass., April 19, 2024--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024, in Chicago, IL.
- Business Wire
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 7, 2024
BEDFORD, Mass., April 09, 2024--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2024 results on Tuesday, May 7, 2024.
- Business Wire
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2023
BEDFORD, Mass., February 28, 2024--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2023.
